Dr Jolynne Mokaya

Wellcome Sanger Institute

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (11)

Natasha Fothergill-Misbah

Newcastle University

UNITED KINGDOM

View details

Catherine Green

Head of the Clinical BioManufacturing Facility

University of Oxford

UNITED KINGDOM

View details

M. Estée Török

University of Cambridge

UNITED KINGDOM

View details

Spyridoula Marinou

University of Oxford

UNITED KINGDOM

View details

Haiting Chai

University of Oxford

UNITED KINGDOM

View details

Anna McNaughton

University of Bristol

UNITED KINGDOM

View details

Cori Campbell

Assistant Professor

University Medical Center Groningen

NETHERLANDS

View details

Philip Baker

University of Oxford

UNITED KINGDOM

View details

George Warimwe

University of Oxford

UNITED KINGDOM

View details

Helene-Mari van der Westhuizen

University of Oxford

UNITED KINGDOM

View details

Daniel Jenkin

University of Oxford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Dr Jolynne Mokaya

Research Interests

Explore related searches

Contact this professor

Articles (10)

A putative hepatitis B virus sequence motif associated with hepatocellular carcinoma in South African adults

Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the field

A consensus statement on dual purpose pathogen surveillance systems: The always on approach

A systematic review and meta-analysis of the risk of hepatitis B virus (HBV) resistance in people treated with entecavir or tenofovir

Social, clinical and biological barriers to hepatitis B virus suppression with nucleos/tide analogue therapy: who is at risk and what should we do about it?

Genomic epidemiology of Streptococcus pneumoniae serotype 16F lineages

Six Action Steps to Address Global Disparities in Parkinson Disease

The global burden of Chikungunya fever among children: A systematic literature review and meta-analysis

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated

Collaborators (11)

Natasha Fothergill-Misbah

Catherine Green

M. Estée Török

Spyridoula Marinou

Haiting Chai

Anna McNaughton

Cori Campbell

Philip Baker

George Warimwe

Helene-Mari van der Westhuizen

Daniel Jenkin

Make your next move.